6 completed, 2 recruiting, 1 active not recruiting, 1 terminated. 7 Phase 2, 6 Phase 1, 1 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 4, Recruiting 1, Terminated 1, Unknown 1 |
| Phase 1 | 6 | Completed 3, Active not recruiting 1, Recruiting 1, Withdrawn 1 |
| Not applicable | 1 | Recruiting 1 |
| Phase 4 | 1 | Completed 1 |
Follow Radioembolization: new trials by email Literature Review of Radioembolization trials Research Report on Radioembolization
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PREDICTT Clinical Trial: Prospective Evaluation Of Pressure-Enabled Delivery And Alterations In CT-Based Tumor-To-Normal Liver Ratio And Tumor Dose Using The Trinav Infusion System Y90 Microsphere Therapy - Tumor, Liver | Not applicable | Recruiting | M.D. Anderson Cancer Center | 20 | 2026-08-01 | 2026-09-01 |
| Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial Angiogram, Biospecimen Collection, Computed Tomography - Stage I Renal Cell Cancer, Stage II Renal Cell Cancer | Phase 1 / Phase 2 | Recruiting | Jonsson Comprehensive Cancer Center | 25 | 2024-12-26 | 2026-08-21 |
| Radioembolization in Elderly/ Fragile Patients With mCRC radioembolization, Standard of care first-line systemic therapy - Colorectal Cancer Metastatic | Phase 2 | Terminated | UMC Utrecht | 18 | 2022-06-01 | 2026-05-14 |
| Safety and Efficacy Study of Radioembolization in Combination With Durvalumab in Locally Advanced and Unresectable HCC Durvalumab, Radioembolization - Hepatocellular Carcinoma | Phase 1 / Phase 2 | Completed | Seoul National University Hospital | 24 | 2020-06-12 | 2023-03-16 |
| Yttrium Y-90 Radioembolization in Treating Patients With Metastatic Liver Cancer Angiography, Computed Tomography, Planar Imaging - Metastatic Liver Carcinoma, Stage IV Liver Cancer | Phase 1 | Active not recruiting | M.D. Anderson Cancer Center | 12 | 2017-01-09 | 2026-09-16 |
| Capecitabine and Y-90 Radioembolization in Treating Patients With Advanced Bile Duct Cancer in the Liver That Cannot Be Removed by Surgery Capecitabine, Laboratory Biomarker Analysis, Radioembolization - Bile Duct Adenocarcinoma, Stage III Intrahepatic Cholangiocarcinoma | Phase 1 | Withdrawn | City of Hope Medical Center | 2016-12-01 | 2017-04-18 | |
| Phase II Trial Evaluating OS With Therasphere® + 2nd-Line FOLFOX in Pancreatic Liver Mets FOLFOX7 (Folinic acid, 5-Fluorouracil, and Oxaliplatin), TheraSpheres - Liver Cancer, Pancreatic Cancer | Phase 2 | Completed | H. Lee Moffitt Cancer Center and Research Institute | 9 | 2012-04-01 | 2017-03-03 |
| Selective Internal Radiation Therapy (SIRT) Versus Transarterial Chemoembolisation (TACE) for the Treatment of Hepatocellular Carcinoma (HCC). DEB TACE, SIRT - Hepatocellular Carcinoma | Phase 4 | Completed | Johannes Gutenberg University Mainz | 24 | 2010-02-01 | 2015-10-20 |
| Clinical Study Examining the Safety and Efficacy of Doxorubicin Drug Eluting Microspheres Transarterial Embolization in the Setting of Hepatocellular Carcinoma (HCC) doxorubicin, superabsorbent polymer microspheres, embolotherapy - Hepatocellular Carcinoma | Phase 1 / Phase 2 | Completed | University of British Columbia | 24 | 2010-01-01 | 2014-03-17 |
| Chemoembolization Versus Radioembolization in Treating Patients With Liver Cancer That Cannot Be Treated With Radiofrequency Ablation Or Surgery yttrium Y 90 glass microspheres, Doxorubicin - Liver Cancer | Phase 2 | Completed | Northwestern University | 45 | 2009-08-01 | 2022-11-21 |
| Y-90 Alone or With Sorafenib for Pre-Transplant Hepatocellular Carcinoma Sorafenib, Yttrium-90 (Y-90) - Hepatocellular Carcinoma | Phase 1 | Completed | Northwestern University | 24 | 2009-02-01 | 2016-09-15 |
| Definitive Therapy for Oligometastatic Solid Malignancies Complete Surgical Removal, Stereotactic Radiosurgery, Ablative external beam radiation dose - Stage IV or Recurrent Carcinoma or Sarcoma | Phase 2 | Unknown | Rocky Mountain Cancer Centers | 110 | 2005-12-01 | 2013-07-15 |
Carcinoma, Hepatocellular (6) · Liver Neoplasms (3) · Carcinoma, Renal Cell (1) · Cholangiocarcinoma (1) · Neoplasm Metastasis (1) · Neoplasms (1) · Pancreatic Neoplasms (1) · Recurrence (1) · Sarcoma (1)
M.D. Anderson Cancer Center (2) · Northwestern University (2) · City of Hope Medical Center (1) · H. Lee Moffitt Cancer Center and Research Institute (1) · Johannes Gutenberg University Mainz (1) · Jonsson Comprehensive Cancer Center (1) · Rocky Mountain Cancer Centers (1) · Seoul National University Hospital (1) · UMC Utrecht (1) · University of British Columbia (1)
United States (8) · Canada (1) · Netherlands (1) · South Korea (1)
Riad Salem, MD (2) · Alan Weiss, MD (1) · Armeen Mahvash (1) · Charles Scudamore, MD (1) · David Owen, MD (1) · Dennise Carter, MD (1) · Ellen Wasan, PhD (1) · Eric Yoshida, MD (1) · Jo-Ann Ford, RN (1) · Jonathan Kessler, MD (1) · Laura Kulik, MD (1) · Peiman Habibollahi, MD (1) · S. Cheenu Kappadath, PHD (1) · Sarah Hoffe, M.D. (1) · Sharlene Gill, MD (1)
PMID 23703789, PMID 24681342, PMID 24982375, PMID 27575820, PMID 41276366
P30CA016672 (1), P30CA060553 (1)